美錦能源(000723.SZ):擬與其他四家企業組成聯合體參與長藥控股重整投資人公開招募
格隆匯3月6日丨美錦能源(000723.SZ)公佈,根據公司發展需要並基於自身產業優勢,經審慎考慮,公司與其他四家企業組成聯合體參與長藥控股重整投資人公開招募,並向長藥控股臨時管理人提交《投資方案》。
公司參與本次重整投資,旨在通過與長藥控股的深度合作,一方面助力長藥控股提升盈利能力,增強市場競爭力,另一方面實現公司與長藥控股的優勢互補,發揮協同效應,爲我國經濟發展注入新活力。公司業務發展前景廣闊,投資長藥控股符合國家關於“高質量發展”和“產業併購”的政策導向。通過此次投資,公司將更好地發揮自身優勢,推動長藥控股產業升級,爲我國經濟發展作出更大貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.